Purchase of pharmaceutical agents for NIAID clinical trials
$194,416Y01FY2019AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
DLA Prime Vendor Program, is an intra-agency agreement that allows DAIT/ NIAID to purchase pharmaceutical agents with streamlined government pricing and negotiations.
View original record on NIH RePORTER →